News

Antibody engineering company f-star appoints three pioneers in antibody engineering and development to its ...

Antibody engineering company f-star appoints three pioneers in antibody engineering and development to its newly...

WWTF: 6 life sciences projects funded with EUR 4.3 million in total

In its meeting on 11 December 2007 the board of directors of WWTF has followed the recommendation of the international...

For the fruit fly, everything changes after sex - IMP researchers find molecular switch for behavioral chan...

For the fruit fly, everything changes after sex - IMP researchers find molecular switch for behavioral changes in flies

Intercell submits marketing authorization application (MAA) to EMEA for licensure of Japanese Encephalitis ...

Intercell submits marketing authorization application (MAA) to EMEA for licensure of Japanese Encephalitis Vaccine

Martin Nowak: Five Rules for Cooperation

Time: 5. 12. 2007, 6:15 p.m.
Place: Autidorium of the Austrian Academy of Sciences

Martin Nowak, Harvard University,...

Statens Serum Institut (SSI), Intercell (ICLL), and Aeras Global Tuberculosis Vaccine Foundation (Aeras) an...

Statens Serum Institut (SSI), Intercell (ICLL), and Aeras Global Tuberculosis Vaccine Foundation (Aeras) announce the...

FWF: Visiting scientists programme Translational Brainpower - Deadline for applications: 27. 3. 2008

The programme goals and Guidelines for applicants for the Translational Research Programme (TRP) are valid. For...

FWF: New Call for Translational Research Projects, Deadline: 27. 3. 2008

The Austrian Science Fund FWF announces a new Call for Translational Research Projects.

Target group:
- Scientists of any...

Fibrex Medical completes enrolment of Phase II trial of treatment for reperfusion injury in myocardial infa...

Fibrex Medical completes enrolment of Phase II trial of treatment for reperfusion injury in myocardial infarction

Intercell's clinical data on Japanese Encephalitis vaccine published in The Lancet

» Intercell´s (ICLL) Phase III clinical trial results on its investigational Japanese Encephalitis vaccine have been...

Antibody engineering company f-star raises EUR 3 million in a second closing of its series A financing roun...

Antibody engineering company f-star raises EUR 3 million in a second closing of its series A financing round from Novo...

Spotlight on life sciences funding in Vienna

On November 26, 2007 aws, FFG, FWF, WWTF and ZIT will inform about news regarding funding of life sciences at the Vienna...